Member Info for PL75

That’s what happened the last time he chatted to Paul Hill Donkey and that’s why I think he needs to get out of the way. He should be all over the strategy, it should be nailed down rather than fumbling around to see where the can has landed for the next hoof. I thought it was the usual superlative display. As in a display of superlatives. Oooh I felt all warm and cosy until I looked at the share price.

Notrex, if you’ve spotted a change in tune it’ll be because the trading position will have changed. That’s what makes the sealion one of the vilest biggest pricks.

Thought it was excellent given pre treatment and the stage the patients were at. Dox is 65%, but it can only be given for so long. Ava6k ticks the boxes to become SoC. Even with the same efficacy the reduced side effects make the difference, with optimisation you can add the potential for better efficacy.

That’s cute. I’d prefer a CEO who can realise potential, not just continually hoof it down the road with WaffAl to continue their lifestyle.

Nice one Bella, just to confirm, you think the raise at 50p when the price was steady in the range 100-140p was a roaring success?

Absolutely RD. They dished out another pile of options just before their brilliant 50p deal. Here’s an alternative….

Hey PIs, I’ll admit I’m useless when it comes to strategy and the M&A thing was a bit weird and a flop, any chance of £20m if I promise to flog Dx and use all that cash get AVA6k to market? Easy raise at a quid. Gets to commercialisation.

Btw, wonder if Myles will still be rolling out the licence deal next week after the presentation.

Good to see people seeing through Alan and not falling for it. He still needs to step down. There were a lot of ifs, buts and maybes. He’s a gaslighting specialist who isn’t shy to boost when it comes to PI presentations. “I like comparators”. Well, get the business in to a state when we’re comparable not languishing at a fraction of the valuation. As ever, happy with the science, Alan is useless. The next presentation will be more WaffAl about the wonderful fund ( including that gormless scrote) and how difficult it was. We’re just liquidity to him. Don’t forget it.

He valued us at 50p a share.

Reported.

Yeah, loved that comment. Pleasure to be of service Alan.

Love the potential, hope it gets realised. It's put in perspective when dox is described as not that toxic when it has the nickname the red devil and only a limited amount can be given before your heart gets trashed. Holy grail is right when you start thinking about more potent warheads being delivered with reduced side effects.

Those specialists were hardly digging deep if Alan also needed other 'high quality' funds - you know, like that gormless scratty **** laughing with Paul Hill about how much of a no brainer it was thanks to the whopping discount.

Poison pill. Problem solved. Mmm delicious poison. BBE, exactly that, it was a shocker but if they keep focussed on getting ava6k to market then it'll play out nicely long term. My expectations are still high as the science continues to prove itself.

Yes, there’s a link. It’s to filter out lazy and stupid people.

"we calculate a value for AVA6000 alone at 89p rising to 182p on the implementation of Phase 2 testing"

Fair old disconnect. Given that view of the value alongside TPs previous valuation prior to continued success in the trial, how come the best they could do was scrabble around backstreet funds wanting a quick buck and offer them 50p. Add in the rest of the business then in less than a year when phase 2 starts we should be knocking on the door of ATHs. Shame it's AIM.

Given all the questions are submitted in advance, I'd hope Alan will be well prepared for a change.

Gje, the only conclusion is that it's trolling. Anyone that's not a sealion would just move on to finding their next duster. We've heard the horrifically lengthy speeches in the past about only caring about the price, that being the case, WTF is the sealion doing all day on a BB waffling about the business - all you'd need is your trusty set of brown crayons. Apparently (evidence suggests very much the absolute opposite), the sealion is a gifted trader (making use of a single indicator prone to whipsaws and guaranteed to result in failure). As a gifted trader, would you linger on an AIM board writing essays on a share with a large bid offer spread. Nope, you'd be off making your pennies on the main market or Fx.

It's a constant stream of gormless contrarian waffle, certainly not worthy of any engagement or discussion. Report, bin, ignore. We've just been given a business update and rather than discuss that, the sealion has been baited for being too quiet. Bfd, you're an Idiot. You get what you ask for. If that floats your boat, crack on, I'll leave my bin full.

Looks positive then? Higher control rate for pretreated population.

I’m m surprised people still respond to a sealion. Black is white. The view will always be contrarian and riddled with enough waffly BS to be right in hindsight. Bin or report the pointless twat. Offers nothing.

Anyone know if that’s normal? Do clinicians typically attend conferences and send out tweets singing the praises of early stage trials? Seems extraordinary tome, but then it’s not my field.

Both discreet and discrete works given it's now separate and hidden. Possibly another blunder, they're hardly putting it in the shop window.